Stem Cell Therapy in Muscular Dystrophy
NCT02241928 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2018-10-25
Summary
The purpose of this study was to analyze the effect of autologous bone marrow mononuclear cells in muscular dystrophy.
Conditions
- Muscular Dystrophy
Interventions
- BIOLOGICAL
-
Stem Cell
Intrathecal Autologous bone marrow mononuclear cell transplantation
Sponsors & Collaborators
-
Neurogen Brain and Spine Institute
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Months
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2018-12-31
- Completion
- 2019-05-31
Countries
- India
Study Locations
More Related Trials
-
Stem Cell Therapy for Amyotrophic Lateral Sclerosis
NCT01984814 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy
NCT01834040 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
NCT03067831 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Exploratory Study of NS-065/NCNP-01 in DMD
NCT02081625 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy
NCT01610440 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT01142856 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT04849065 ·Status: UNKNOWN ·Phase: PHASE2
-
Exploratory Study of NS-089/NCNP-02 in DMD
NCT04129294 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Muscle Tissue Bank for Muscular Dystrophy
NCT01950897 ·Status: COMPLETED
-
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
NCT02972580 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2
NCT02484560 ·Status: UNKNOWN ·Phase: PHASE1
-
Expanded Access Study of UC-MSC in DMD Patients
NCT06579352 ·Status: AVAILABLE
-
Trial of Cell Based Therapy for DMD
NCT06692426 ·Status: RECRUITING ·Phase: PHASE1
-
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
NCT01380964 ·Status: COMPLETED
-
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
NCT00468832 ·Status: UNKNOWN
-
Neurologic Stem Cell Treatment Study
NCT02795052 ·Status: RECRUITING ·Phase: NA
-
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
NCT06532474 ·Status: RECRUITING
-
Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital
NCT05029232 ·Status: UNKNOWN ·Phase: NA
-
Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis
NCT02383654 ·Status: COMPLETED ·Phase: PHASE1
-
Mesenchymal Stem Cell Therapy in Multiple System Atrophy
NCT02315027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)
NCT03268603 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy
NCT02285673 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia
NCT04385056 ·Status: UNKNOWN ·Phase: PHASE1
-
Gentamicin Treatment of Muscular Dystrophy
NCT00005574 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT02881489 ·Status: UNKNOWN ·Phase: PHASE1